Adoptive Immunotherapy
specificA technique for enhancing cell-mediated immunity by: 1) artificially increasing the number of specific immunocompetent cells through inoculation of either ex-vivo expanded primarily activated cytotoxic lymphocytes or genetically engineered lymphocytes with enhanced cytotoxic ability or 2) by altering tumor cells to make them more immunogenic.
7
Centers
0
Active Trials
$26M
Cancer Funding
Top Centers for Adoptive Immunotherapy(7)
Ranked by research excellence score (trials · grants · publications). Methodology →
| # | Center | Score |
|---|---|---|
| 1 | Mayo Clinic Comprehensive Cancer CenterRochester, MN NCI Comprehensive High-Volume Research Center | 72.1 |
| 2 | Memorial Sloan Kettering Cancer CenterNew York, NY NCI Comprehensive Active Research Program | 67.1 |
| 3 | UPMC Hillman Cancer CenterPittsburgh, PA NCI Comprehensive Active Research Program | 62.1 |
| 4 | Abramson Cancer Center of the University of PennsylvaniaPhiladelphia, PA NCI Comprehensive Active Research Program | 57.1 |
| 5 | Moffitt Cancer CenterTampa, FL NCI Comprehensive Active Research Program | 52.1 |
| 6 | Dartmouth Cancer CenterLebanon, NH NCI Comprehensive Active Research Program | 47.1 |
| 7 | Dana-Farber Cancer InstituteBoston, MA NCI Comprehensive Active Research Program | 42.1 |
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →